Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders
Maddalena Mereu, Antonello Bonci, Amy Hauck Newman, et al.
Psychopharmacology (2013) Vol. 229, Iss. 3, pp. 415-434
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Deficits in behavioural inhibition in substance abuse and addiction: A meta-analysis
Janette L. Smith, Richard P. Mattick, Sharna D. Jamadar, et al.
Drug and Alcohol Dependence (2014) Vol. 145, pp. 1-33
Closed Access | Times Cited: 504
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review
Gustavo A. Angarita, Nazli Emadi, Sarah E. Hodges, et al.
Addiction Science & Clinical Practice (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 294
Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management
Chitra Lal, Terri E. Weaver, Charles Bae, et al.
Annals of the American Thoracic Society (2021) Vol. 18, Iss. 5, pp. 757-768
Open Access | Times Cited: 146
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter
Maarten E. A. Reith, Bruce E. Blough, Weimin Hong, et al.
Drug and Alcohol Dependence (2014) Vol. 147, pp. 1-19
Open Access | Times Cited: 125
Cognition and addiction
Antonio Verdejo‐García, Gloria García–Fernández, Geert Dom
Dialogues in Clinical Neuroscience (2019) Vol. 21, Iss. 3, pp. 281-290
Open Access | Times Cited: 122
Chronic methamphetamine self-administration disrupts cortical control of cognition
Aurélien P. Bernheim, Ronald E. See, Carmela M. Reichel
Neuroscience & Biobehavioral Reviews (2016) Vol. 69, pp. 36-48
Open Access | Times Cited: 92
Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders
Mehmet Sofuoglu, Elise E. DeVito, Andrew J. Waters, et al.
Journal of Dual Diagnosis (2016) Vol. 12, Iss. 1, pp. 90-106
Open Access | Times Cited: 90
Pharmacological treatments for methamphetamine addiction: current status and future directions
Javier Ballester, Gerald Valentine, Mehmet Sofuoglu
Expert Review of Clinical Pharmacology (2016), pp. 1-10
Closed Access | Times Cited: 88
Benefits and Harms of ‘Smart Drugs’ (Nootropics) in Healthy Individuals
Fabrizio Schifano, Valeria Catalani, Safia Sharif, et al.
Drugs (2022) Vol. 82, Iss. 6, pp. 633-647
Open Access | Times Cited: 39
An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil
Eric Murillo‐Rodríguez, André Barciela Veras, Nuno Rocha, et al.
ACS Chemical Neuroscience (2017) Vol. 9, Iss. 2, pp. 151-158
Closed Access | Times Cited: 81
Serotonin, neural markers, and memory
Alfredo Meneses
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 80
5-HT systems: emergent targets for memory formation and memory alterations
Alfredo Meneses
Reviews in the Neurosciences (2013) Vol. 24, Iss. 6
Closed Access | Times Cited: 78
Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial
Andreas G. Franke, Patrik Gränsmark, Alexandra Agricola, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 3, pp. 248-260
Closed Access | Times Cited: 76
Psychostimulant addiction treatment
Karran A. Phillips, David H. Epstein, Kenzie L. Preston
Neuropharmacology (2014) Vol. 87, pp. 150-160
Open Access | Times Cited: 73
Cortico-Amygdala Coupling as a Marker of Early Relapse Risk in Cocaine-Addicted Individuals
Meredith McHugh, Catherine H. Demers, Betty Jo Salmeron, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 72
The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population
Shameka L. Cody, David E. Vance
Neurobiology of Disease (2016) Vol. 92, pp. 144-156
Closed Access | Times Cited: 68
Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors
Jianjing Cao, Rachel D. Slack, Oluyomi M. Bakare, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10676-10691
Open Access | Times Cited: 63
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman, et al.
Neuropharmacology (2019) Vol. 158, pp. 107609-107609
Open Access | Times Cited: 62
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders
Amy Hauck Newman, Therese Ku, Chloe J. Jordan, et al.
The Annual Review of Pharmacology and Toxicology (2021) Vol. 61, Iss. 1, pp. 609-628
Open Access | Times Cited: 47
Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects
Wei‐Lun Sun, Pamela M. Quizon, Jun Zhu
Progress in molecular biology and translational science (2015), pp. 1-40
Open Access | Times Cited: 63
Modafinil decreases anxiety-like behaviour in zebrafish
Adrian Johnson, Trevor J. Hamilton
PeerJ (2017) Vol. 5, pp. e2994-e2994
Open Access | Times Cited: 59
Modafinil improves methamphetamine-induced object recognition deficits and restores prefrontal cortex ERK signaling in mice
Betina González, Mariana Raineri, Jean Lud Cadet, et al.
Neuropharmacology (2014) Vol. 87, pp. 188-197
Open Access | Times Cited: 58
Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits
Verónica Bisagno, Betina González, Francisco J. Urbano
Pharmacological Research (2016) Vol. 109, pp. 108-118
Open Access | Times Cited: 55
Pharmacological profile of methylphenidate-based designer drugs
Dino Luethi, Philine J. Kaeser, Simon D. Brandt, et al.
Neuropharmacology (2017) Vol. 134, pp. 133-140
Open Access | Times Cited: 55
A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa–carbidopa, naltrexone
Joy M. Schmitz, Charles E. Green, Angela L. Stotts, et al.
Drug and Alcohol Dependence (2014) Vol. 136, pp. 100-107
Open Access | Times Cited: 54
Page 1 - Next Page

Scroll to top